发明名称 3-ureidoisoquinolin-8-yl derivatives
摘要 The invention relates to 3-ureidoisoquinolin-8-yl derivatives of formula I;whereinR1 is alkyl, haloalkyl or cyclopropyl;R2 is H, halogen, pyridazin-4-yl, pyrimidin-5-yl or an optionally substituted pyridin-3-yl, pyridin-4-yl or phenyl group;R3 is alkyl, alkynyl, aminoalkyl, carbamoylalkyl, methylcarbamoylalkyl, alkoxy, haloalkoxy, alkynyloxy, (4-hydroxybut-2-yn-1-yl)oxy, (4-aminobut-2-yn-1-yl)oxy, dimethylaminoalkoxy, carbamoylalkoxy, alkylamino, cycloalkyl, cycloalkylalkyl, cycloalkylalkoxy, hydroxyalkyl, hydroxyalkoxy, alkoxyalkyl, alkoxyalkoxy, carboxyalkyl, carboxyalkoxy, alkoxycarbonylalkoxy, aryl, heteroaryl, benzyl, benzyloxy, 2-cyanoethoxy, 2,3-dihydroxypropoxy, 3,4-dihydroxybutoxy, —CH2Ra, —CH2CH2Rb, —(CH2)n—C(O)O—Rd, —(CH2)n—N(Rc)C(O)O—Rd, —O—(CH2)n—N(Rc)C(O)O—Rd, —(CH2)n—Re or —O—(CH2)n—Re; Ra is cyano, acetylamino or N,N-dimethylamino; Rb is cyano or carbamoyl; Rc is H or methyl; Rd is alkyl; Re is pyrrolidin-1-yl, piperidin-1-yl, piperidin-3-yl, morpholin-1-yl, 2-oxopyrrolidin-1-yl, 5-oxopyrrolidin-2-yl, 2,5-dioxopyrrolidin-1-yl, 2-oxoimidazolidin-1-yl, 4-(tert-butoxycarbonyl)piperazin-1-yl, 4-(aminomethyl)cyclohexyl or heteroaryl;R4 is H or methyl;and to the salts of such compounds.These compounds are useful for the prevention or the treatment of bacterial infections.
申请公布号 US8889676(B2) 申请公布日期 2014.11.18
申请号 US201214009093 申请日期 2012.03.28
申请人 Actelion Pharmaceuticals Ltd. 发明人 Gude Markus;Hubschwerlen Christian;Panchaud Philippe
分类号 C07D217/22;C07D401/04;A61K31/472;C07D401/12;C07D401/14 主分类号 C07D217/22
代理机构 Hunton & Williams LLP 代理人 Hunton & Williams LLP
主权项 1. A compound of formula I wherein R1 is (C1-C3)alkyl, (C2-C3)haloalkyl or cyclopropyl; R2 is H, halogen, pyridazin-4-yl, pyrimidin-5-yl or a group having the formula (A1), (A2) or (A3) shown hereafter wherein Rx is H and each of Ry and Rz is independently H or methyl, or each of Rx and Rz is H and Ry is halogen, cyano, (C2-C4)alkyl, (C1-C4)alkoxy, amino, hydroxy, hydroxy-(C1-C3)alkyl, trifluoromethyl, carbamoyl, carbamoyl-(C1-C2)alkyl, (methylcarbamoyl)-(C1-C2)alkyl, (dimethylcarbamoyl)-(C1-C2)alkyl, tert-butoxycarbonylmethyl, cyclopropyl, pyrrolidin-1-yl, piperidin-1-yl, morpholin-1-yl or 1-morpholinomethyl, or Rx is H and each of Ry and Rz is independently halogen, or Rx is methyl, Ry is methyl or halogen and Rz is H, or Rx is methyl or halogen, Ry is H and Rz is methyl or halogen, or Rx is methyl or halogen and each of Ry and Rz is H; Rx2 is H, amino or hydroxymethyl; Rx3 is hydroxy, carboxy, carbamoyl, hydroxymethyl or aminomethyl, Ry3 is H and Rz3 is H or each of Rx3 and Rz3 is H and Ry3 is hydroxy, acetamidomethyl, (dimethylamino)methyl, carboxymethyl, carbamoyl or aminomethyl, or each of Rx3 and Ry3 is H and Rz3 is hydroxy; R3 is (C1-C4)alkyl, (C2-C4)alkynyl, amino-(C1-C3)alkyl, carbamoyl-(C1-C3)alkyl, (methylcarbamoyl)-(C1-C3)alkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C3-C4)alkynyloxy, (4-hydroxybut-2-yn-1-yl)oxy, (4-aminobut-2-yn-1-yl)oxy, dimethylamino-(C2-C3)alkoxy, carbamoyl-(C1-C3)alkoxy, (C1-C3)alkylamino, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C1-C4)alkyl, (C3-C6)cycloalkyl-(C1-C4)alkoxy, hydroxy-(C1-C3)alkyl, hydroxy-(C2-C3)alkoxy, (C1-C3)alkoxy-(C1-C3)alkyl, (C1-C3)alkoxy-(C1-C3)alkoxy, carboxy-(C1-C3)alkyl, carboxy-(C1-C3)alkoxy, (C1-C2)alkoxycarbonyl-(C1-C3)alkoxy, aryl, (C5-C6)heteroaryl, benzyl, benzyloxy, 2-cyanoethoxy, 2,3-dihydroxypropoxy, 3,4-dihydroxybutoxy, —CH2Ra, —CH2CH2Rb, —(CH2)n—C(O)O—Rd, —(CH2)n—N(Rc)C(O)O—Rd, —O—(CH2)n—N(Rc)C(O)O—Rd, —(CH2)n—Re or —O—(CH2)n—Re; n is 1, 2 or 3; Ra is cyano, acetylamino, N,N-dimethylamino; and Rb is cyano or carbamoyl; Rc is H or methyl; Rd is (C1-C4)alkyl; Re is pyrrolidin-1-yl, piperidin-1-yl, piperidin-3-yl, morpholin-1-yl, 2-oxopyrrolidin-1-yl, 5-oxopyrrolidin-2-yl, 2,5-dioxopyrrolidin-1-yl, 2-oxoimidazolidin-1-yl, 4-(tert-butoxycarbonyl)piperazin-1-yl, 4-(aminomethyl)cyclohexyl or (C5-C6)heteroaryl; R4 is H or methyl; or a salt thereof.
地址 Allschwil CH